• Join
  • Login
  • Contact

Search abstracts / presentations

Compounding personalized medication: when is it appropriate?

  • At: Glasgow (Scotland) (2018)
  • Type: Poster
  • Poster code: POS-PHT-003
  • By: JENSEN, Brenda (Compounding Consultants, LLC)
  • Co-author(s): Brenda S Jensen: Compounding Consultants, LLC., Sioux Falls, United States
    Lisa Diggs Ashworth: Pharmacy, Children's Health System of Texas, Dallas, United States
    Eddy Hack: Compounding Consultants, LLC., Sioux Falls, United States
  • Abstract:


    Room Carron


    Pharmacies in the United States must be licensed in their resident state and states where they ship or deliver medications.  Each state has its own rules and regulations regarding compounding.  Amid safety concerns, the Drug Quality and Security Act (DQSA) was passed in 2013 and mandates restrictions on compounding,


  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses